

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.09173751 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.09173751 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 5.09173751 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.09173751 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 5.09173751 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.09173751 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.77509422 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.45875109 |
| 9 | regulation of integrin activation (GO:0033623) | 4.12810525 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 4.10453338 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.92890321 |
| 12 | cellular extravasation (GO:0045123) | 3.88605056 |
| 13 | I-kappaB phosphorylation (GO:0007252) | 3.88597701 |
| 14 | cellular response to ethanol (GO:0071361) | 3.72618547 |
| 15 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.59772986 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.59772986 |
| 17 | histone H3-K9 demethylation (GO:0033169) | 3.50726767 |
| 18 | microglial cell activation (GO:0001774) | 3.49880634 |
| 19 | negative regulation of granulocyte differentiation (GO:0030853) | 3.47011917 |
| 20 | positive regulation of interferon-alpha production (GO:0032727) | 3.37069620 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 3.31090710 |
| 22 | daunorubicin metabolic process (GO:0044597) | 3.27605411 |
| 23 | polyketide metabolic process (GO:0030638) | 3.27605411 |
| 24 | doxorubicin metabolic process (GO:0044598) | 3.27605411 |
| 25 | regulation of interferon-alpha production (GO:0032647) | 3.15269647 |
| 26 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.15089475 |
| 27 | response to host immune response (GO:0052572) | 3.14900354 |
| 28 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.14900354 |
| 29 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 3.08025137 |
| 30 | mannose metabolic process (GO:0006013) | 3.02437726 |
| 31 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.00826074 |
| 32 | response to host (GO:0075136) | 3.00826074 |
| 33 | response to host defenses (GO:0052200) | 3.00826074 |
| 34 | oligosaccharide catabolic process (GO:0009313) | 3.00511988 |
| 35 | macrophage activation (GO:0042116) | 2.95434375 |
| 36 | positive regulation of interferon-beta production (GO:0032728) | 2.93676155 |
| 37 | NLS-bearing protein import into nucleus (GO:0006607) | 2.93673179 |
| 38 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.89950035 |
| 39 | histone H3-K36 demethylation (GO:0070544) | 2.89468452 |
| 40 | macroautophagy (GO:0016236) | 2.89206547 |
| 41 | histone lysine demethylation (GO:0070076) | 2.89117132 |
| 42 | regulation of gamma-delta T cell activation (GO:0046643) | 2.87195266 |
| 43 | negative regulation of interleukin-12 production (GO:0032695) | 2.86635177 |
| 44 | substrate-dependent cell migration (GO:0006929) | 2.86551107 |
| 45 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.85990687 |
| 46 | pinocytosis (GO:0006907) | 2.85671430 |
| 47 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.85277468 |
| 48 | histone demethylation (GO:0016577) | 2.84789671 |
| 49 | positive thymic T cell selection (GO:0045059) | 2.83779567 |
| 50 | glycosphingolipid catabolic process (GO:0046479) | 2.82770236 |
| 51 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.82298626 |
| 52 | positive regulation of chemokine secretion (GO:0090197) | 2.81617802 |
| 53 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.78968236 |
| 54 | coronary vasculature morphogenesis (GO:0060977) | 2.78912795 |
| 55 | cell adhesion mediated by integrin (GO:0033627) | 2.77761314 |
| 56 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.77066363 |
| 57 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.75231553 |
| 58 | response to peptidoglycan (GO:0032494) | 2.72790661 |
| 59 | plasma lipoprotein particle assembly (GO:0034377) | 2.72681595 |
| 60 | response to laminar fluid shear stress (GO:0034616) | 2.69583633 |
| 61 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.69384986 |
| 62 | positive regulation of p38MAPK cascade (GO:1900745) | 2.69365386 |
| 63 | regulation of mononuclear cell migration (GO:0071675) | 2.68593532 |
| 64 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.68498717 |
| 65 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.68498717 |
| 66 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.68498717 |
| 67 | protein-lipid complex assembly (GO:0065005) | 2.67619271 |
| 68 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.67049981 |
| 69 | modulation by symbiont of host cellular process (GO:0044068) | 2.65819949 |
| 70 | B cell homeostasis (GO:0001782) | 2.64731294 |
| 71 | regulation of chemokine secretion (GO:0090196) | 2.64058752 |
| 72 | G-protein coupled receptor internalization (GO:0002031) | 2.63726395 |
| 73 | wound healing, spreading of epidermal cells (GO:0035313) | 2.63407711 |
| 74 | regulation of interferon-beta production (GO:0032648) | 2.60978145 |
| 75 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.59048986 |
| 76 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.55914673 |
| 77 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.53607035 |
| 78 | skin morphogenesis (GO:0043589) | 2.53046791 |
| 79 | protein localization to endosome (GO:0036010) | 2.53023535 |
| 80 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.52676611 |
| 81 | positive regulation of extracellular matrix organization (GO:1903055) | 2.52221839 |
| 82 | regulation of apoptotic cell clearance (GO:2000425) | 2.51716017 |
| 83 | nerve growth factor signaling pathway (GO:0038180) | 2.51233396 |
| 84 | protein dealkylation (GO:0008214) | 2.51141020 |
| 85 | protein demethylation (GO:0006482) | 2.51141020 |
| 86 | pore complex assembly (GO:0046931) | 2.49480962 |
| 87 | myeloid cell activation involved in immune response (GO:0002275) | 2.48202496 |
| 88 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.48076243 |
| 89 | fibroblast migration (GO:0010761) | 2.47270357 |
| 90 | apoptotic cell clearance (GO:0043277) | 2.47061152 |
| 91 | response to lipoprotein particle (GO:0055094) | 2.46224808 |
| 92 | glycolipid catabolic process (GO:0019377) | 2.45752676 |
| 93 | response to muramyl dipeptide (GO:0032495) | 2.44889886 |
| 94 | monocyte chemotaxis (GO:0002548) | 2.42867625 |
| 95 | positive T cell selection (GO:0043368) | 2.42824518 |
| 96 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.42125689 |
| 97 | peptide catabolic process (GO:0043171) | 2.41879712 |
| 98 | regulation of macrophage chemotaxis (GO:0010758) | 2.41171645 |
| 99 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.40995664 |
| 100 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.39958541 |
| 101 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.39659573 |
| 102 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.39496828 |
| 103 | Golgi to endosome transport (GO:0006895) | 2.39438987 |
| 104 | negative regulation of B cell proliferation (GO:0030889) | 2.38632394 |
| 105 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.38383349 |
| 106 | detection of biotic stimulus (GO:0009595) | 2.38371628 |
| 107 | regulation of RNA export from nucleus (GO:0046831) | 2.37429963 |
| 108 | pre-miRNA processing (GO:0031054) | 2.36507283 |
| 109 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.34416353 |
| 110 | cholesterol efflux (GO:0033344) | 2.32124352 |
| 111 | plasma membrane repair (GO:0001778) | 2.30126609 |
| 112 | nuclear pore complex assembly (GO:0051292) | 2.29677941 |
| 113 | positive regulation of antigen processing and presentation (GO:0002579) | 2.27015074 |
| 114 | mature B cell differentiation (GO:0002335) | 2.26169369 |
| 115 | detection of external biotic stimulus (GO:0098581) | 2.25637397 |
| 116 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.25397863 |
| 117 | germinal center formation (GO:0002467) | 2.24026956 |
| 118 | establishment of nucleus localization (GO:0040023) | 2.23971613 |
| 119 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.23313544 |
| 120 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.22531208 |
| 121 | positive regulation of receptor recycling (GO:0001921) | 2.22467344 |
| 122 | immunoglobulin mediated immune response (GO:0016064) | 2.21081218 |
| 123 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.20968993 |
| 124 | intestinal epithelial cell development (GO:0060576) | 2.20619937 |
| 125 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.20378684 |
| 126 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.20152033 |
| 127 | negative regulation of stress fiber assembly (GO:0051497) | 2.19859364 |
| 128 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.19111099 |
| 129 | negative regulation of macroautophagy (GO:0016242) | 2.18460587 |
| 130 | negative regulation of bone resorption (GO:0045779) | 2.16085021 |
| 131 | ruffle organization (GO:0031529) | 2.15545608 |
| 132 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.14566534 |
| 133 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.14393119 |
| 134 | natural killer cell mediated immunity (GO:0002228) | 2.14393119 |
| 135 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.14255756 |
| 136 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.14207962 |
| 137 | venous blood vessel morphogenesis (GO:0048845) | 2.13178731 |
| 138 | histone mRNA catabolic process (GO:0071044) | 2.12990305 |
| 139 | cellular response to interferon-alpha (GO:0035457) | 2.12695387 |
| 140 | striated muscle atrophy (GO:0014891) | 2.11840988 |
| 141 | axon extension involved in axon guidance (GO:0048846) | 2.11783349 |
| 142 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.11783349 |
| 143 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.11560802 |
| 144 | negative regulation of protein activation cascade (GO:2000258) | 2.11438191 |
| 145 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.09935698 |
| 146 | negative regulation of complement activation (GO:0045916) | 2.09612140 |
| 147 | regulation of extracellular matrix organization (GO:1903053) | 2.08852791 |
| 148 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.07490068 |
| 149 | negative regulation of anoikis (GO:2000811) | 2.07308424 |
| 150 | myeloid dendritic cell differentiation (GO:0043011) | 2.07181449 |
| 151 | T-helper 1 type immune response (GO:0042088) | 2.07093133 |
| 152 | embryonic process involved in female pregnancy (GO:0060136) | 2.06639716 |
| 153 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.06251020 |
| 154 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.05376872 |
| 155 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.04917279 |
| 156 | COPII vesicle coating (GO:0048208) | 2.03743940 |
| 157 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.03737392 |
| 158 | ceramide catabolic process (GO:0046514) | 2.02236128 |
| 159 | protein targeting to vacuole (GO:0006623) | 1.99926905 |
| 160 | protein targeting to lysosome (GO:0006622) | 1.99926905 |
| 161 | establishment of protein localization to vacuole (GO:0072666) | 1.99926905 |
| 162 | osteoclast differentiation (GO:0030316) | 1.97841399 |
| 163 | negative regulation of humoral immune response (GO:0002921) | 1.96810493 |
| 164 | regulation of T cell tolerance induction (GO:0002664) | 1.96746399 |
| 165 | skeletal muscle adaptation (GO:0043501) | 1.95564223 |
| 166 | histone H3-K4 trimethylation (GO:0080182) | 1.95481668 |
| 167 | cellular response to nerve growth factor stimulus (GO:1990090) | 1.95195711 |
| 168 | response to nerve growth factor (GO:1990089) | 1.95195711 |
| 169 | neutrophil activation involved in immune response (GO:0002283) | 1.94971552 |
| 170 | regulation of tolerance induction (GO:0002643) | 1.94537425 |
| 171 | mRNA modification (GO:0016556) | 1.94027439 |
| 172 | regulation of necroptotic process (GO:0060544) | 1.93838828 |
| 173 | Rap protein signal transduction (GO:0032486) | 1.92183916 |
| 174 | interkinetic nuclear migration (GO:0022027) | 1.91964874 |
| 175 | regulation of histone H3-K27 methylation (GO:0061085) | 1.90686354 |
| 176 | protein targeting to Golgi (GO:0000042) | 1.88443533 |
| 177 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 1.87736993 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 4.66234220 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.64384550 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.53972027 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.53718189 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.36323946 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.36179797 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.25602773 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.21375238 |
| 9 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.19606191 |
| 10 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.03757814 |
| 11 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.02523012 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.95499805 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.74232031 |
| 14 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.73784169 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.65057047 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.51637658 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.42642685 |
| 18 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.38048213 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.23995777 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.21483451 |
| 21 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.16420984 |
| 22 | SPI1_23127762_ChIP-Seq_K562_Human | 2.11936186 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.06894526 |
| 24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.03371806 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.00849114 |
| 26 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88766854 |
| 27 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.86349086 |
| 28 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.83760403 |
| 29 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.83183317 |
| 30 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.76212055 |
| 31 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.75936520 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72937304 |
| 33 | MYC_22102868_ChIP-Seq_BL_Human | 1.70977779 |
| 34 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.64956497 |
| 35 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.63814251 |
| 36 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.63814251 |
| 37 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.59324234 |
| 38 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.59083683 |
| 39 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.58095608 |
| 40 | TP53_16413492_ChIP-PET_HCT116_Human | 1.52229688 |
| 41 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.46766824 |
| 42 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.45386054 |
| 43 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.44457979 |
| 44 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.40279024 |
| 45 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.39741561 |
| 46 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.39598329 |
| 47 | MYB_26560356_Chip-Seq_TH1_Human | 1.38839657 |
| 48 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.38496205 |
| 49 | * VDR_24787735_ChIP-Seq_THP-1_Human | 1.36909626 |
| 50 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.36708318 |
| 51 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.36301818 |
| 52 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.36240332 |
| 53 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35308738 |
| 54 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.34290353 |
| 55 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.33767991 |
| 56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.32993973 |
| 57 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.32064852 |
| 58 | MYB_26560356_Chip-Seq_TH2_Human | 1.31559186 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.31103511 |
| 60 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.30763844 |
| 61 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.30090635 |
| 62 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.30090635 |
| 63 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.29652789 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29459140 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.27509547 |
| 66 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27362760 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25825328 |
| 68 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25571561 |
| 69 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.24975297 |
| 70 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23291397 |
| 71 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.22897550 |
| 72 | MAF_26560356_Chip-Seq_TH1_Human | 1.22784718 |
| 73 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.19727889 |
| 74 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19553481 |
| 75 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.18596972 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.18372081 |
| 77 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18167356 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17767057 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17545461 |
| 80 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14695916 |
| 81 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.13943929 |
| 82 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12999779 |
| 83 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.12811593 |
| 84 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.12811593 |
| 85 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.11870115 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11531300 |
| 87 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11348993 |
| 88 | RXR_22108803_ChIP-Seq_LS180_Human | 1.10688437 |
| 89 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.10095241 |
| 90 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10056250 |
| 91 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.10014206 |
| 92 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.09730686 |
| 93 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09432603 |
| 94 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09352373 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.09174033 |
| 96 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08648724 |
| 97 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07814501 |
| 98 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.06498283 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.06091572 |
| 100 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.05533315 |
| 101 | STAT3_23295773_ChIP-Seq_U87_Human | 1.05489004 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05023636 |
| 103 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03824943 |
| 104 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03188726 |
| 105 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.02574761 |
| 106 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02255218 |
| 107 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.02089080 |
| 108 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01697019 |
| 109 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.01384623 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00458803 |
| 111 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.99196643 |
| 112 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98830986 |
| 113 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.98737004 |
| 114 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.98577952 |
| 115 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98483285 |
| 116 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.98139680 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98129486 |
| 118 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.97320678 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97200336 |
| 120 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96806284 |
| 121 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96728673 |
| 122 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96653221 |
| 123 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96651000 |
| 124 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96609290 |
| 125 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96576839 |
| 126 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95359781 |
| 127 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.94851236 |
| 128 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.94727407 |
| 129 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93165481 |
| 130 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.92936510 |
| 131 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.92563808 |
| 132 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91631821 |
| 133 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.91509420 |
| 134 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91196210 |
| 135 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90546926 |
| 136 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.89361160 |
| 137 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.89101433 |
| 138 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88754484 |
| 139 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88158202 |
| 140 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.88087435 |
| 141 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88048460 |
| 142 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.87305544 |
| 143 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.87107752 |
| 144 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.86899181 |
| 145 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.86864365 |
| 146 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.86563908 |
| 147 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82520233 |
| 148 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.81470486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.98093277 |
| 2 | MP0003172_abnormal_lysosome_physiology | 3.44942712 |
| 3 | MP0002396_abnormal_hematopoietic_system | 2.89086413 |
| 4 | MP0006054_spinal_hemorrhage | 2.78143399 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.59911194 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.49042243 |
| 7 | MP0003566_abnormal_cell_adhesion | 2.47345375 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.46051475 |
| 9 | MP0010352_gastrointestinal_tract_polyps | 2.18203552 |
| 10 | MP0008260_abnormal_autophagy | 2.16163823 |
| 11 | MP0003693_abnormal_embryo_hatching | 2.14416935 |
| 12 | MP0005076_abnormal_cell_differentiation | 2.11308347 |
| 13 | MP0003303_peritoneal_inflammation | 2.07233463 |
| 14 | MP0002877_abnormal_melanocyte_morpholog | 2.07080361 |
| 15 | MP0003656_abnormal_erythrocyte_physiolo | 2.06823700 |
| 16 | MP0005451_abnormal_body_composition | 2.02933298 |
| 17 | MP0010307_abnormal_tumor_latency | 2.01444491 |
| 18 | MP0001835_abnormal_antigen_presentation | 1.96007466 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 1.87837818 |
| 20 | MP0000604_amyloidosis | 1.86999685 |
| 21 | MP0003221_abnormal_cardiomyocyte_apopto | 1.84370078 |
| 22 | MP0002419_abnormal_innate_immunity | 1.82715176 |
| 23 | MP0005671_abnormal_response_to | 1.82542263 |
| 24 | MP0006082_CNS_inflammation | 1.77985974 |
| 25 | MP0005257_abnormal_intraocular_pressure | 1.77425432 |
| 26 | MP0003690_abnormal_glial_cell | 1.77217595 |
| 27 | MP0001849_ear_inflammation | 1.75744539 |
| 28 | MP0003828_pulmonary_edema | 1.72982933 |
| 29 | MP0008438_abnormal_cutaneous_collagen | 1.70092604 |
| 30 | MP0001800_abnormal_humoral_immune | 1.68309984 |
| 31 | MP0000015_abnormal_ear_pigmentation | 1.67478147 |
| 32 | MP0002452_abnormal_antigen_presenting | 1.66876677 |
| 33 | MP0004947_skin_inflammation | 1.66317552 |
| 34 | MP0003091_abnormal_cell_migration | 1.63770068 |
| 35 | MP0000371_diluted_coat_color | 1.57698504 |
| 36 | MP0000490_abnormal_crypts_of | 1.53850039 |
| 37 | MP0004185_abnormal_adipocyte_glucose | 1.52466057 |
| 38 | MP0005174_abnormal_tail_pigmentation | 1.50113190 |
| 39 | MP0002998_abnormal_bone_remodeling | 1.48822393 |
| 40 | MP0003436_decreased_susceptibility_to | 1.47676830 |
| 41 | MP0003195_calcinosis | 1.47551155 |
| 42 | MP0002332_abnormal_exercise_endurance | 1.47522218 |
| 43 | MP0010234_abnormal_vibrissa_follicle | 1.47361739 |
| 44 | MP0005248_abnormal_Harderian_gland | 1.46594228 |
| 45 | MP0004808_abnormal_hematopoietic_stem | 1.45053599 |
| 46 | MP0003045_fibrosis | 1.43266049 |
| 47 | MP0005023_abnormal_wound_healing | 1.42131401 |
| 48 | MP0003878_abnormal_ear_physiology | 1.41980855 |
| 49 | MP0005377_hearing/vestibular/ear_phenot | 1.41980855 |
| 50 | MP0005464_abnormal_platelet_physiology | 1.41817883 |
| 51 | MP0003329_amyloid_beta_deposits | 1.41163257 |
| 52 | MP0003111_abnormal_nucleus_morphology | 1.39970164 |
| 53 | MP0000343_altered_response_to | 1.38384156 |
| 54 | MP0003950_abnormal_plasma_membrane | 1.37172723 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.36517781 |
| 56 | MP0002723_abnormal_immune_serum | 1.35828539 |
| 57 | MP0001819_abnormal_immune_cell | 1.34326842 |
| 58 | MP0009278_abnormal_bone_marrow | 1.34204532 |
| 59 | MP0005000_abnormal_immune_tolerance | 1.32131228 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.30979385 |
| 61 | MP0000733_abnormal_muscle_development | 1.30515260 |
| 62 | MP0005409_darkened_coat_color | 1.27822312 |
| 63 | MP0004233_abnormal_muscle_weight | 1.27751210 |
| 64 | MP0001790_abnormal_immune_system | 1.27444492 |
| 65 | MP0005387_immune_system_phenotype | 1.27444492 |
| 66 | MP0010155_abnormal_intestine_physiology | 1.24644902 |
| 67 | MP0003890_abnormal_embryonic-extraembry | 1.24565172 |
| 68 | MP0005670_abnormal_white_adipose | 1.23793397 |
| 69 | MP0005025_abnormal_response_to | 1.19196108 |
| 70 | MP0000767_abnormal_smooth_muscle | 1.18200020 |
| 71 | MP0002166_altered_tumor_susceptibility | 1.16296573 |
| 72 | MP0004084_abnormal_cardiac_muscle | 1.14409813 |
| 73 | MP0002896_abnormal_bone_mineralization | 1.12774661 |
| 74 | MP0002006_tumorigenesis | 1.11874797 |
| 75 | MP0004036_abnormal_muscle_relaxation | 1.09580544 |
| 76 | MP0002398_abnormal_bone_marrow | 1.09306355 |
| 77 | MP0000920_abnormal_myelination | 1.08733187 |
| 78 | MP0004215_abnormal_myocardial_fiber | 1.08295326 |
| 79 | MP0003724_increased_susceptibility_to | 1.08245067 |
| 80 | MP0002168_other_aberrant_phenotype | 1.07532349 |
| 81 | MP0001533_abnormal_skeleton_physiology | 1.06316874 |
| 82 | MP0000383_abnormal_hair_follicle | 1.05903938 |
| 83 | MP0005164_abnormal_response_to | 1.05480459 |
| 84 | MP0002148_abnormal_hypersensitivity_rea | 1.05330171 |
| 85 | MP0003868_abnormal_feces_composition | 1.04697783 |
| 86 | MP0009780_abnormal_chondrocyte_physiolo | 1.04219632 |
| 87 | MP0009697_abnormal_copulation | 1.04165819 |
| 88 | MP0003448_altered_tumor_morphology | 1.03985733 |
| 89 | MP0003634_abnormal_glial_cell | 1.03952652 |
| 90 | MP0004510_myositis | 1.03105275 |
| 91 | MP0000716_abnormal_immune_system | 1.00829659 |
| 92 | MP0008004_abnormal_stomach_pH | 0.99681415 |
| 93 | MP0002405_respiratory_system_inflammati | 0.99125070 |
| 94 | MP0009840_abnormal_foam_cell | 0.98497793 |
| 95 | MP0003191_abnormal_cellular_cholesterol | 0.98394007 |
| 96 | MP0010678_abnormal_skin_adnexa | 0.98383079 |
| 97 | MP0002972_abnormal_cardiac_muscle | 0.97750760 |
| 98 | MP0001958_emphysema | 0.97520150 |
| 99 | MP0002971_abnormal_brown_adipose | 0.95172267 |
| 100 | MP0003122_maternal_imprinting | 0.95167765 |
| 101 | MP0004130_abnormal_muscle_cell | 0.94879701 |
| 102 | MP0003279_aneurysm | 0.94465993 |
| 103 | MP0000703_abnormal_thymus_morphology | 0.94364804 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.93493163 |
| 105 | MP0002928_abnormal_bile_duct | 0.93277342 |
| 106 | MP0002722_abnormal_immune_system | 0.93039018 |
| 107 | MP0002009_preneoplasia | 0.93004214 |
| 108 | MP0004272_abnormal_basement_membrane | 0.93000963 |
| 109 | MP0000689_abnormal_spleen_morphology | 0.92847584 |
| 110 | MP0005330_cardiomyopathy | 0.92749280 |
| 111 | MP0001845_abnormal_inflammatory_respons | 0.91633396 |
| 112 | MP0001545_abnormal_hematopoietic_system | 0.91553973 |
| 113 | MP0005397_hematopoietic_system_phenotyp | 0.91553973 |
| 114 | MP0003252_abnormal_bile_duct | 0.89236364 |
| 115 | MP0009384_cardiac_valve_regurgitation | 0.88274887 |
| 116 | MP0002060_abnormal_skin_morphology | 0.86918608 |
| 117 | MP0001915_intracranial_hemorrhage | 0.86314369 |
| 118 | MP0004264_abnormal_extraembryonic_tissu | 0.85916256 |
| 119 | MP0010094_abnormal_chromosome_stability | 0.85764370 |
| 120 | MP0000750_abnormal_muscle_regeneration | 0.85390356 |
| 121 | MP0009785_altered_susceptibility_to | 0.85165510 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.84946194 |
| 123 | MP0000858_altered_metastatic_potential | 0.84598927 |
| 124 | MP0006138_congestive_heart_failure | 0.84526191 |
| 125 | MP0004087_abnormal_muscle_fiber | 0.84251192 |
| 126 | MP0002429_abnormal_blood_cell | 0.83304609 |
| 127 | MP0003984_embryonic_growth_retardation | 0.82459431 |
| 128 | MP0002088_abnormal_embryonic_growth/wei | 0.81961086 |
| 129 | MP0010368_abnormal_lymphatic_system | 0.81472271 |
| 130 | MP0002075_abnormal_coat/hair_pigmentati | 0.80245937 |
| 131 | MP0009115_abnormal_fat_cell | 0.80200137 |
| 132 | MP0003183_abnormal_peptide_metabolism | 0.80007696 |
| 133 | MP0000685_abnormal_immune_system | 0.79761454 |
| 134 | MP0002086_abnormal_extraembryonic_tissu | 0.78438099 |
| 135 | MP0002269_muscular_atrophy | 0.78268253 |
| 136 | MP0005310_abnormal_salivary_gland | 0.76679193 |
| 137 | MP0004883_abnormal_blood_vessel | 0.76209089 |
| 138 | MP0001672_abnormal_embryogenesis/_devel | 0.76057462 |
| 139 | MP0005380_embryogenesis_phenotype | 0.76057462 |
| 140 | MP0003941_abnormal_skin_development | 0.73339420 |
| 141 | MP0003632_abnormal_nervous_system | 0.72888308 |
| 142 | MP0005621_abnormal_cell_physiology | 0.71227504 |
| 143 | MP0004484_altered_response_of | 0.71036406 |
| 144 | MP0000249_abnormal_blood_vessel | 0.70843479 |
| 145 | MP0005197_abnormal_uvea_morphology | 0.70786665 |
| 146 | MP0005375_adipose_tissue_phenotype | 0.69776700 |
| 147 | MP0010630_abnormal_cardiac_muscle | 0.69570923 |
| 148 | MP0002925_abnormal_cardiovascular_devel | 0.68868390 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Urethral obstruction (HP:0000796) | 3.95470960 |
| 2 | Cerebral aneurysm (HP:0004944) | 3.38074961 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 3.33361265 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.08050494 |
| 5 | Aortic aneurysm (HP:0004942) | 3.05213981 |
| 6 | Abnormality of macrophages (HP:0004311) | 2.87361333 |
| 7 | Prostate neoplasm (HP:0100787) | 2.83901563 |
| 8 | Papillary thyroid carcinoma (HP:0002895) | 2.83851181 |
| 9 | Neurofibrillary tangles (HP:0002185) | 2.80676252 |
| 10 | Chronic diarrhea (HP:0002028) | 2.77250280 |
| 11 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.75376861 |
| 12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.75376861 |
| 13 | Abnormality of glycolipid metabolism (HP:0010969) | 2.75376861 |
| 14 | Hematochezia (HP:0002573) | 2.73234221 |
| 15 | Recurrent fungal infections (HP:0002841) | 2.71909232 |
| 16 | Cheilitis (HP:0100825) | 2.70574117 |
| 17 | Eczematoid dermatitis (HP:0000976) | 2.69689363 |
| 18 | Loss of speech (HP:0002371) | 2.67115888 |
| 19 | Cervical subluxation (HP:0003308) | 2.66874215 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 2.64072643 |
| 21 | Increased cerebral lipofuscin (HP:0011813) | 2.63855970 |
| 22 | Pustule (HP:0200039) | 2.59888189 |
| 23 | Global brain atrophy (HP:0002283) | 2.58655822 |
| 24 | Abnormality of the fingertips (HP:0001211) | 2.56904648 |
| 25 | Periodontitis (HP:0000704) | 2.55560462 |
| 26 | Alopecia of scalp (HP:0002293) | 2.54376256 |
| 27 | Autoimmune thrombocytopenia (HP:0001973) | 2.50898640 |
| 28 | Heterotopia (HP:0002282) | 2.45248834 |
| 29 | Disinhibition (HP:0000734) | 2.44096168 |
| 30 | Gingivitis (HP:0000230) | 2.43315099 |
| 31 | Recurrent cutaneous fungal infections (HP:0011370) | 2.41661743 |
| 32 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.41661743 |
| 33 | Mitral stenosis (HP:0001718) | 2.39443036 |
| 34 | Apathy (HP:0000741) | 2.31304824 |
| 35 | Premature loss of primary teeth (HP:0006323) | 2.27351102 |
| 36 | Thyroiditis (HP:0100646) | 2.25881579 |
| 37 | Eosinophilia (HP:0001880) | 2.25751125 |
| 38 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.25434317 |
| 39 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.25348690 |
| 40 | Peritonitis (HP:0002586) | 2.23032724 |
| 41 | Thick nail (HP:0001805) | 2.21492804 |
| 42 | Mitral valve prolapse (HP:0001634) | 2.19476563 |
| 43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16220081 |
| 44 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16220081 |
| 45 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16220081 |
| 46 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.16095543 |
| 47 | Osteolytic defects of the hand bones (HP:0009699) | 2.16019098 |
| 48 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.16019098 |
| 49 | Cerebral inclusion bodies (HP:0100314) | 2.14427427 |
| 50 | Oligodontia (HP:0000677) | 2.12178456 |
| 51 | Deep venous thrombosis (HP:0002625) | 2.10543183 |
| 52 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.10038013 |
| 53 | Recurrent viral infections (HP:0004429) | 2.09109523 |
| 54 | Shallow orbits (HP:0000586) | 2.08295682 |
| 55 | Absent frontal sinuses (HP:0002688) | 2.07474412 |
| 56 | Arterial tortuosity (HP:0005116) | 2.07089893 |
| 57 | Spondylolisthesis (HP:0003302) | 2.04946739 |
| 58 | Abnormality of eosinophils (HP:0001879) | 2.03980372 |
| 59 | Aortic dissection (HP:0002647) | 1.99143027 |
| 60 | Glomerulonephritis (HP:0000099) | 1.98205464 |
| 61 | Bone pain (HP:0002653) | 1.97017257 |
| 62 | Abnormality of the ischium (HP:0003174) | 1.96907633 |
| 63 | Diminished motivation (HP:0000745) | 1.94869880 |
| 64 | Broad palm (HP:0001169) | 1.92918276 |
| 65 | Subacute progressive viral hepatitis (HP:0006572) | 1.92533806 |
| 66 | Protuberant abdomen (HP:0001538) | 1.92401309 |
| 67 | Frequent falls (HP:0002359) | 1.91692671 |
| 68 | Narrow palate (HP:0000189) | 1.90859481 |
| 69 | Myocardial infarction (HP:0001658) | 1.90791249 |
| 70 | T lymphocytopenia (HP:0005403) | 1.90370092 |
| 71 | Spinal cord lesions (HP:0100561) | 1.89995565 |
| 72 | Syringomyelia (HP:0003396) | 1.89995565 |
| 73 | Increased connective tissue (HP:0009025) | 1.88996669 |
| 74 | Leukocytosis (HP:0001974) | 1.88822611 |
| 75 | Prominent nose (HP:0000448) | 1.88536290 |
| 76 | Tetraparesis (HP:0002273) | 1.88399651 |
| 77 | Premature rupture of membranes (HP:0001788) | 1.88041751 |
| 78 | Asymmetric septal hypertrophy (HP:0001670) | 1.87547728 |
| 79 | Combined immunodeficiency (HP:0005387) | 1.86995605 |
| 80 | Dilatation of the ascending aorta (HP:0005111) | 1.86018365 |
| 81 | Vascular tortuosity (HP:0004948) | 1.85458899 |
| 82 | Aneurysm (HP:0002617) | 1.85121631 |
| 83 | Epidermoid cyst (HP:0200040) | 1.83622348 |
| 84 | Flat acetabular roof (HP:0003180) | 1.82840960 |
| 85 | Severe combined immunodeficiency (HP:0004430) | 1.82616665 |
| 86 | Abnormal foot bone ossification (HP:0010675) | 1.82606055 |
| 87 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.81635943 |
| 88 | Recurrent skin infections (HP:0001581) | 1.81452108 |
| 89 | Vertebral arch anomaly (HP:0008438) | 1.79675255 |
| 90 | Disproportionate tall stature (HP:0001519) | 1.79567737 |
| 91 | Distal lower limb amyotrophy (HP:0008944) | 1.79426435 |
| 92 | Hypoplasia of the thymus (HP:0000778) | 1.79200977 |
| 93 | Retrobulbar optic neuritis (HP:0100654) | 1.78087045 |
| 94 | Optic neuritis (HP:0100653) | 1.78087045 |
| 95 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.77326358 |
| 96 | Mucopolysacchariduria (HP:0008155) | 1.77326358 |
| 97 | Skin nodule (HP:0200036) | 1.76757779 |
| 98 | Dysostosis multiplex (HP:0000943) | 1.76352200 |
| 99 | Anal stenosis (HP:0002025) | 1.75678657 |
| 100 | Coarse hair (HP:0002208) | 1.75499310 |
| 101 | Widely spaced teeth (HP:0000687) | 1.74347656 |
| 102 | Neurodegeneration (HP:0002180) | 1.73512743 |
| 103 | Esophageal varix (HP:0002040) | 1.72868162 |
| 104 | Sparse lateral eyebrow (HP:0005338) | 1.72857821 |
| 105 | Neuronal loss in central nervous system (HP:0002529) | 1.72646901 |
| 106 | Termporal pattern (HP:0011008) | 1.72349904 |
| 107 | Insidious onset (HP:0003587) | 1.72349904 |
| 108 | Complement deficiency (HP:0004431) | 1.71710817 |
| 109 | Macroorchidism (HP:0000053) | 1.71659747 |
| 110 | Abnormality of T cell number (HP:0011839) | 1.71470726 |
| 111 | Genu recurvatum (HP:0002816) | 1.71166443 |
| 112 | Amyloidosis (HP:0011034) | 1.71041760 |
| 113 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.70924318 |
| 114 | Persistence of primary teeth (HP:0006335) | 1.69768653 |
| 115 | Tibial bowing (HP:0002982) | 1.69148259 |
| 116 | Colitis (HP:0002583) | 1.68700780 |
| 117 | Low anterior hairline (HP:0000294) | 1.68063028 |
| 118 | Agnosia (HP:0010524) | 1.68033482 |
| 119 | Supranuclear gaze palsy (HP:0000605) | 1.67860100 |
| 120 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.67467034 |
| 121 | Increased density of long bones (HP:0006392) | 1.67328064 |
| 122 | Bladder carcinoma (HP:0002862) | 1.67217631 |
| 123 | Bladder neoplasm (HP:0009725) | 1.67217631 |
| 124 | Orchitis (HP:0100796) | 1.66660741 |
| 125 | Vacuolated lymphocytes (HP:0001922) | 1.66177155 |
| 126 | Nephritis (HP:0000123) | 1.65763118 |
| 127 | Ectopic kidney (HP:0000086) | 1.64769488 |
| 128 | Large earlobe (HP:0009748) | 1.64487889 |
| 129 | Cupped ribs (HP:0000887) | 1.64362424 |
| 130 | Tapered finger (HP:0001182) | 1.63879443 |
| 131 | Hyperacusis (HP:0010780) | 1.63419048 |
| 132 | Atrophic scars (HP:0001075) | 1.62363300 |
| 133 | Granulocytopenia (HP:0001913) | 1.61111985 |
| 134 | Long eyelashes (HP:0000527) | 1.60639797 |
| 135 | Open mouth (HP:0000194) | 1.60057291 |
| 136 | Ulnar bowing (HP:0003031) | 1.59823909 |
| 137 | Elfin facies (HP:0004428) | 1.59774669 |
| 138 | Wide nose (HP:0000445) | 1.59460916 |
| 139 | Renal cell carcinoma (HP:0005584) | 1.58991940 |
| 140 | Leiomyosarcoma (HP:0100243) | 1.58675148 |
| 141 | Uterine leiomyosarcoma (HP:0002891) | 1.58675148 |
| 142 | Neonatal short-limb short stature (HP:0008921) | 1.58439023 |
| 143 | Increased CSF protein (HP:0002922) | 1.57989967 |
| 144 | Inappropriate behavior (HP:0000719) | 1.57888574 |
| 145 | Thin bony cortex (HP:0002753) | 1.57732800 |
| 146 | Pathologic fracture (HP:0002756) | 1.57650784 |
| 147 | Chromsome breakage (HP:0040012) | 1.57306714 |
| 148 | Viral hepatitis (HP:0006562) | 1.56684978 |
| 149 | Hypoplastic ischia (HP:0003175) | 1.55986810 |
| 150 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.55627109 |
| 151 | Broad face (HP:0000283) | 1.55492643 |
| 152 | Scanning speech (HP:0002168) | 1.54971403 |
| 153 | Osteomyelitis (HP:0002754) | 1.54439409 |
| 154 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.54185441 |
| 155 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.53428487 |
| 156 | Gastrointestinal infarctions (HP:0005244) | 1.52620794 |
| 157 | Right ventricular cardiomyopathy (HP:0011663) | 1.52418203 |
| 158 | Dislocated radial head (HP:0003083) | 1.52354350 |
| 159 | Truncal obesity (HP:0001956) | 1.52135809 |
| 160 | Thickened calvaria (HP:0002684) | 1.52066654 |
| 161 | Axonal loss (HP:0003447) | 1.52055413 |
| 162 | Mitral regurgitation (HP:0001653) | 1.52029471 |
| 163 | Nuclear cataract (HP:0100018) | 1.51415499 |
| 164 | Onion bulb formation (HP:0003383) | 1.50701420 |
| 165 | Abnormality of the frontal sinuses (HP:0002687) | 1.50401316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 3.60425460 |
| 2 | CAMK1D | 3.48272003 |
| 3 | TGFBR2 | 3.01019651 |
| 4 | CAMK1G | 2.63193849 |
| 5 | SIK2 | 2.56760263 |
| 6 | DDR2 | 2.53348819 |
| 7 | TTN | 2.21820895 |
| 8 | STK10 | 2.19205798 |
| 9 | SIK1 | 1.99796861 |
| 10 | TYK2 | 1.89853970 |
| 11 | PDGFRA | 1.88149290 |
| 12 | JAK1 | 1.86748268 |
| 13 | LATS1 | 1.83725619 |
| 14 | KSR1 | 1.78027932 |
| 15 | YES1 | 1.69099946 |
| 16 | MAP3K13 | 1.67543741 |
| 17 | MAP3K14 | 1.67487798 |
| 18 | MAP4K1 | 1.64463422 |
| 19 | CSF1R | 1.62550206 |
| 20 | KSR2 | 1.59003157 |
| 21 | STK3 | 1.50790738 |
| 22 | MAP3K10 | 1.42639984 |
| 23 | RIPK4 | 1.41637814 |
| 24 | CASK | 1.40890143 |
| 25 | MARK3 | 1.39239159 |
| 26 | RIPK1 | 1.34378755 |
| 27 | MAP3K3 | 1.32579080 |
| 28 | IRAK1 | 1.29100181 |
| 29 | MAP3K9 | 1.24113782 |
| 30 | NEK9 | 1.24098659 |
| 31 | EEF2K | 1.23740890 |
| 32 | PDGFRB | 1.23667672 |
| 33 | AKT3 | 1.23041475 |
| 34 | TXK | 1.22833923 |
| 35 | MAP2K3 | 1.21898369 |
| 36 | BLK | 1.21673173 |
| 37 | TAOK3 | 1.21632485 |
| 38 | MAP3K6 | 1.19797014 |
| 39 | PKN2 | 1.18964225 |
| 40 | TTK | 1.18857969 |
| 41 | HCK | 1.18248121 |
| 42 | PTK6 | 1.17043905 |
| 43 | CSK | 1.15657971 |
| 44 | EPHB1 | 1.15655896 |
| 45 | ERBB3 | 1.15109984 |
| 46 | STK24 | 1.14026261 |
| 47 | NEK2 | 1.13393892 |
| 48 | TRIB3 | 1.13241039 |
| 49 | IRAK3 | 1.12993142 |
| 50 | MST1R | 1.12393676 |
| 51 | BRD4 | 1.12120209 |
| 52 | STK38L | 1.10978779 |
| 53 | MAP3K2 | 1.10326452 |
| 54 | EPHA2 | 1.06796988 |
| 55 | MATK | 1.06516938 |
| 56 | TRPM7 | 1.06188256 |
| 57 | ALK | 1.05771888 |
| 58 | MAP3K7 | 1.03801032 |
| 59 | SGK3 | 1.03618153 |
| 60 | TNIK | 1.01930004 |
| 61 | PRPF4B | 1.01633400 |
| 62 | BCR | 1.01180223 |
| 63 | RET | 1.00387707 |
| 64 | IRAK2 | 0.99875198 |
| 65 | MOS | 0.97902034 |
| 66 | FGR | 0.97631077 |
| 67 | ERN1 | 0.97576132 |
| 68 | EIF2AK2 | 0.97542247 |
| 69 | ZAP70 | 0.97315729 |
| 70 | CAMKK2 | 0.97156157 |
| 71 | TAOK1 | 0.96108154 |
| 72 | TBK1 | 0.93586283 |
| 73 | MTOR | 0.93225896 |
| 74 | NLK | 0.91996002 |
| 75 | PAK4 | 0.91738438 |
| 76 | MAP3K4 | 0.89967702 |
| 77 | JAK3 | 0.88647744 |
| 78 | KIT | 0.86551050 |
| 79 | MAP3K1 | 0.85879664 |
| 80 | FGFR3 | 0.84732276 |
| 81 | SIK3 | 0.84353380 |
| 82 | GRK7 | 0.83582404 |
| 83 | ERBB4 | 0.82678875 |
| 84 | RPS6KA4 | 0.81696772 |
| 85 | MAP3K8 | 0.80968377 |
| 86 | FGFR2 | 0.80559134 |
| 87 | EPHA3 | 0.79731014 |
| 88 | PIK3CA | 0.79680808 |
| 89 | CDK6 | 0.79072605 |
| 90 | IKBKB | 0.78577409 |
| 91 | CHUK | 0.77042721 |
| 92 | PRKAA2 | 0.74849395 |
| 93 | ZAK | 0.74033377 |
| 94 | MARK2 | 0.71569116 |
| 95 | IRAK4 | 0.71443564 |
| 96 | ITK | 0.70939358 |
| 97 | STK4 | 0.70850491 |
| 98 | NUAK1 | 0.70386983 |
| 99 | PAK2 | 0.69604719 |
| 100 | SGK2 | 0.67406255 |
| 101 | SCYL2 | 0.65211051 |
| 102 | ROCK1 | 0.65174544 |
| 103 | CDC42BPA | 0.63442847 |
| 104 | PNCK | 0.63438308 |
| 105 | FGFR1 | 0.60370016 |
| 106 | LCK | 0.60137947 |
| 107 | FGFR4 | 0.59797397 |
| 108 | ROCK2 | 0.58688665 |
| 109 | ACVR1B | 0.58483115 |
| 110 | ATR | 0.58222831 |
| 111 | CAMK4 | 0.57834728 |
| 112 | MAPK11 | 0.56607484 |
| 113 | PIM1 | 0.55802001 |
| 114 | IKBKE | 0.54138814 |
| 115 | PDK1 | 0.51697785 |
| 116 | DMPK | 0.51680290 |
| 117 | WNK1 | 0.50825398 |
| 118 | RAF1 | 0.50524387 |
| 119 | PDPK1 | 0.50318937 |
| 120 | LYN | 0.49582871 |
| 121 | PRKAA1 | 0.49490979 |
| 122 | EGFR | 0.49411984 |
| 123 | ICK | 0.49285912 |
| 124 | INSRR | 0.48525289 |
| 125 | STK38 | 0.48478829 |
| 126 | MELK | 0.46540582 |
| 127 | SGK1 | 0.45781458 |
| 128 | FER | 0.45698445 |
| 129 | AKT2 | 0.45110465 |
| 130 | SYK | 0.43854647 |
| 131 | CLK1 | 0.43202016 |
| 132 | MAPK10 | 0.43037184 |
| 133 | JAK2 | 0.42939050 |
| 134 | IGF1R | 0.42220285 |
| 135 | TYRO3 | 0.41996570 |
| 136 | MARK1 | 0.40024949 |
| 137 | MAP3K5 | 0.39301801 |
| 138 | MAPK12 | 0.38905501 |
| 139 | BMX | 0.38129057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18611860 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.13176646 |
| 3 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.06525996 |
| 4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.94952210 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.80570096 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.76939195 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.68121402 |
| 8 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66538369 |
| 9 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59909142 |
| 10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.52732128 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.51235161 |
| 12 | Tuberculosis_Homo sapiens_hsa05152 | 1.47721120 |
| 13 | Measles_Homo sapiens_hsa05162 | 1.44115756 |
| 14 | Lysosome_Homo sapiens_hsa04142 | 1.43615038 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.42593038 |
| 16 | Adherens junction_Homo sapiens_hsa04520 | 1.40819437 |
| 17 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40219448 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.36626782 |
| 19 | Influenza A_Homo sapiens_hsa05164 | 1.35982724 |
| 20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.35789328 |
| 21 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.34488399 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.34157805 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31652759 |
| 24 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.30618731 |
| 25 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28596552 |
| 26 | Lysine degradation_Homo sapiens_hsa00310 | 1.28594876 |
| 27 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28562635 |
| 28 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.24162870 |
| 29 | Apoptosis_Homo sapiens_hsa04210 | 1.22396725 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.21721598 |
| 31 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.21287471 |
| 32 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19297513 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.16075911 |
| 34 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15023450 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.13198036 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.12190702 |
| 37 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.11923868 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.11195462 |
| 39 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.10734720 |
| 40 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.10629725 |
| 41 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09906454 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09870826 |
| 43 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.07547371 |
| 44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.05680074 |
| 45 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04283136 |
| 46 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03861412 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.02013221 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.01203689 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99108290 |
| 50 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.98173283 |
| 51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98157357 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.94456466 |
| 53 | Malaria_Homo sapiens_hsa05144 | 0.93959478 |
| 54 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93096097 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92806325 |
| 56 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91793311 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 0.91709707 |
| 58 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.91169419 |
| 59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.91126667 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 0.90783532 |
| 61 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.89999189 |
| 62 | Legionellosis_Homo sapiens_hsa05134 | 0.88012524 |
| 63 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.87225974 |
| 64 | HTLV-I infection_Homo sapiens_hsa05166 | 0.86849323 |
| 65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86513164 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.86232239 |
| 67 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.85249604 |
| 68 | Focal adhesion_Homo sapiens_hsa04510 | 0.85112101 |
| 69 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.82936888 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.82795512 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.81430787 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.80505692 |
| 73 | Platelet activation_Homo sapiens_hsa04611 | 0.79540297 |
| 74 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79492299 |
| 75 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78850546 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.78739697 |
| 77 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.78516169 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77911658 |
| 79 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.77611709 |
| 80 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77598030 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77453545 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.76266920 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.75773745 |
| 84 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.75579761 |
| 85 | Amoebiasis_Homo sapiens_hsa05146 | 0.74237924 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.72977153 |
| 87 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72624170 |
| 88 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.72039996 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.71936038 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71388903 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71379410 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.70838622 |
| 93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70826845 |
| 94 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70624394 |
| 95 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70425434 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70023714 |
| 97 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69620214 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.69022105 |
| 99 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.68584837 |
| 100 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67748207 |
| 101 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67687113 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.67606350 |
| 103 | Insulin resistance_Homo sapiens_hsa04931 | 0.66816580 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.66327752 |
| 105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63315712 |
| 106 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.61970563 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.60066498 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.58808975 |
| 109 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58715800 |
| 110 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.57766188 |
| 111 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57365291 |
| 112 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56245992 |
| 113 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.55339615 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.54401976 |
| 115 | Melanoma_Homo sapiens_hsa05218 | 0.54395816 |
| 116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53231153 |
| 117 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53082866 |
| 118 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.52528510 |
| 119 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.51765508 |
| 120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50802395 |
| 121 | Endocytosis_Homo sapiens_hsa04144 | 0.46956778 |

